Advertisement

Topics

Nutra Pharma Corporation Company Profile

06:08 EST 18th December 2018 | BioPortfolio

Nutra Pharma Corp. (OTCBB: NPHC) is a biopharmaceutical company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases.
Nutra Pharma Corp. through its subsidiaries carries out basic drug discovery research and clinical development and also seeks strategic licensing partnerships to reduce the risks associated with the drug development process. The Company's holding, ReceptoPharm, Inc., is developing technologies for the production of drugs for HIV and Multiple Sclerosis ("MS"). The Company's subsidiary, Designer Diagnostics, is engaged in the research and development of diagnostic test kits designed to be used for the rapid identification of infectious diseases such as Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI)

Location

791 Park of Commerce Blvd.Suite 300
Boca Raton
Florida
33487
United States of America

Contact

Phone: (954) 509-0911
Fax: (877) 895-5647
Email: info@NutraPharma.com


News Articles [552 Associated News Articles listed on BioPortfolio]

Mandatory notification of trade

Valborg Godal Vold, COO of Vistin Pharma ASA, and a primary insider, has on 18 September 2018 sold 50,000 shares in Vistin Pharma ASA at an average price of NOK 10.58 per share. Following this sa...

Nutra Pharma Corp NPHC Financial and Strategic SWOT Analysis Review [Report Updated: 30052018] Prices from USD $125

Nutra Pharma Corp NPHC Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by Global...

Opti-Nutra™ Advanced Nutraceuticals Introduces BioGenesis™ Nature-Identical Vitamin and Mineral Essentials

BioGenesis™ vitamins and minerals are lab-grown using patented, eco-friendly technology that enhances bioavailability and optimizes nutritional benefits for peak biological performance. LONDON (PRWE...

Opti-Nutra™ Launches Performance Lab® Supplements for Human Performance Optimization

Opti-Nutra™ Advanced Nutraceuticals has announced its launch of the Performance Lab® nutritional supplement line with 11 advanced formulations for human performance optimization. LONDON (PRWEB)...

Herantis Pharma Plc's financial reporting schedule and annual general meeting in 2019

Herantis Pharma Plc's financial reporting schedule and annual general meeting in 2019 Herantis Pharma Plc. Company release 18 December 2018 at 9:00 am Herantis Pharma Plc ("Hera...

Zealand Pharma to attend Jefferies and Bryan, Garnier & Co Healthcare Conferences

Press release - No. 23 / 2018 Zealand Pharma to attend Jefferies and Bryan, Garnier & Co Healthcare Conferences Copenhagen, November 12, 2018 - Britt Meelby Jensen, President ...

Nutra Pharma Corp NPHC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryNutra Pharma Corp Nutra Pharma acquires, licenses and commercializes pharmaceutical products, technologies, homeopathic drugs and ethical drugs for managing cancer, neurological disorders, auto...

Nutra Pharma Corp NPHC Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryNutra Pharma Corp Nutra Pharma acquires, licenses and commercializes pharmaceutical products, technologies, homeopathic drugs and ethical drugs for managing cancer, neurological disorders, auto...

PubMed Articles [22 Associated PubMed Articles listed on BioPortfolio]

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Clinical trials go virtual, big pharma dives in.

Disease awareness advertising (DAA) in emerging economy: A comparison between views of consumers and pharmaceutical professionals.

Research on effectiveness of DAA is limited. Existing researches explore impact of DAA only on relationship between drug manufacturers and consumers. However, in reality, pharma marketing revolves aro...

21 Century Citizen Pharma: The FDA & Patient-Focused Product Development.

Perpetual debate regarding the delicate balance between access and innovation and the protection of the public health and safety dominate discussions of the United States Food and Drug Administration ...

The Common Pharmaceutical Market of the Eurasian Economic Union: A Regulatory Review.

According to the Treaty on the Eurasian Economic Union, a common pharmaceutical market was supposed to become operational on January 1, 2016. Nevertheless, the responsible parties did not meet the dea...

Clinical Trials [85 Associated Clinical Trials listed on BioPortfolio]

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

The primary objective is to determine clinical bioequivalence of Amphotericin B liposome for injection of Auromedics Pharma LLC, USA and AmBisome (Amphotericin B) liposome for injection of...

Companies [963 Associated Companies listed on BioPortfolio]

L-Nutra, Inc.

L-Nutra’s team of researchers and collaborators are leaders in the field of nutrition related to longevity and healthspan. L-Nutra has the exclusive rights from the Universit...

Nutra Pharma Corp.

Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the ...

Stevia Nutra Corporation

Stevia Nutra is an Agro-Management company focused on stevia agronomics which includes plant breeding, proprietary agricultural practices and post-harvest techniques. Stevia Nutra...

Nutra Pharma Corporation

Nutra Pharma Corp. (OTCBB: NPHC) is a biopharmaceutical company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neuro...

Nutra Summa

More Information about "Nutra Pharma Corporation" on BioPortfolio

We have published hundreds of Nutra Pharma Corporation news stories on BioPortfolio along with dozens of Nutra Pharma Corporation Clinical Trials and PubMed Articles about Nutra Pharma Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nutra Pharma Corporation Companies in our database. You can also find out about relevant Nutra Pharma Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record